Text size A - A+

Lotemax® Eye Drops 0.5% (Anti-Inflammation)

LotemaxSterile-5ml-218x202

Key Features & Benefits

  • Indicated for the treatment of steroid responsive eye inflammatory conditions
  • Ophthalmic suspension dosage form designed for the eye surface

Note: This eye drop requires doctors prescription

Indications

LOTEMAX® is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye such as allergic conjunctivitis, giant papillary conjunctivitis and seasonal allergic conjunctivitis.

LOTEMAX® is also indicated for the treatment of post-operative inflammation following ocular surgery.


How often should you use?

Shake vigorously before use.

Steroid Responsive Disease Treatment:
Apply 1 to 2 drops of Lotemax® into the conjunctival sac of the affected eye(s) 4 times daily. During the initial treatment within the first week, the dosing may be increased, up to 1 drop every hour, if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve two days, the patient should be re-evaluated (refer to PRECAUTIONS in product insert).

Post-Operative Inflammation:
Apply 1 to 2 drops of Lotemax® into the conjunctival sac of the operated eye(s) 4 times daily, beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period.


Ingredients

Loteprednol etabonate 5mg/ml (0.5%), edetate disodium, glycerin, povidone, purified water, tyloxapol, benzalkonium chloride (0.01%), hydrochloric acid, sodium hydroxide.


Presentation

Lotemax® (loteprednol etabonate ophthalmic suspension) is supplied in a plastic bottle with a controlled drop tip in a 5ml bottle.


Important information about using Lotemax® Eye Drops 0.5%

Note: Please consult a doctor prior to using this product.

General: For ophthalmic use only. The initial prescription and renewal of the medication order beyond 14 days should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy and, where appropriate, fluorescein staining.

If signs and symptoms fail to improve after two days, the patient should be re-evaluated.

If this product is used for 10 days or longer, intraocular pressure should be monitored even though it may be difficult in children and uncooperative patients (see WARNINGS in product insert).

Fungal infections of the cornea are particularly prone to develop coincidentally with long-term local steroid application. Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal cultures should be taken when appropriate.

This product is sterile when packaged. Please be advised that the dropper tip should not touch any surface, as this may contaminate the suspension. The bottle should be closed immediately after use.



Warnings

Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Steroids should be used with caution in the presence of glaucoma.

Prolonged use of corticosteroids may suppress the host response and thus increase the hazard of secondary ocular infections. In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids. In acute purulent conditions of the eye, steroids may mask infection or enhance existing infection.

Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution.

The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.

References

1. Singapore approved product information.